PlainRecalls
FDA Drug Critical Class I Terminated

Titanium 4000, capsule, 4000 mg, 1 count blister card, 30 blister display boxt, distributed by Titanium 4000 UPC 86077000020

Reported: May 22, 2019 Initiated: April 23, 2019 #D-1292-2019

Product Description

Titanium 4000, capsule, 4000 mg, 1 count blister card, 30 blister display boxt, distributed by Titanium 4000 UPC 86077000020

Reason for Recall

Marketed without an approved NDA/ANDA: undeclared sildenafil and tadalafil.

Details

Recalling Firm
D.B.P. Distribution
Units Affected
unknown
Distribution
Nationwide.
Location
Chatsworth, CA

Frequently Asked Questions

What product was recalled?
Titanium 4000, capsule, 4000 mg, 1 count blister card, 30 blister display boxt, distributed by Titanium 4000 UPC 86077000020. Recalled by D.B.P. Distribution. Units affected: unknown.
Why was this product recalled?
Marketed without an approved NDA/ANDA: undeclared sildenafil and tadalafil.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 22, 2019. Severity: Critical. Recall number: D-1292-2019.